Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
The Power of Antibody-Based Surveillance | NEJM
Antibody - Wikipedia
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | Science
Antibodies | Free Full-Text | Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses
Anti-SARS-CoV-2 Monoclonal Antibodies
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production - ScienceDirect
A guide to vaccinology: from basic principles to new developments | Nature Reviews Immunology
Inflammation | Bio-Rad
Switchable assembly and function of antibody complexes in vivo using a small molecule | PNAS
20.6D: Immunological Memory - Medicine LibreTexts
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
Duration of Humoral Immunity to Common Viral and Vaccine Antigens | NEJM
A long-term perspective on immunity to COVID
Single B cell technologies for monoclonal antibody discovery: Trends in Immunology
Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling | National Institutes of Health (NIH)
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England - The
Lasting immunity found after recovery from COVID-19 | National Institutes of Health (NIH)
Pharmaceutics | Free Full-Text | Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein ...
Frontiers | Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES - Chiara Zecca, Claudio Gobbi, 2022
Antibodies | Free Full-Text | Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines
Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies | Molecular Pharmaceutics
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses | ACS Nano
The humoral response and antibodies against SARS-CoV-2 infection | Nature Immunology
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade - eBioMedicine
